RTP biotech targeting stroke treatments raises $27.5M, Business NC reports
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors. Here are the details.
Read MorePosted by WRAL TechWire | Nov 16, 2023
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors. Here are the details.
Read MorePosted by WRAL TechWire | Feb 15, 2022
For adults who have had a stroke staying on top of dental care may prevent a second stroke, according to research co-authored by the University of North Carolina at Chapel Hill and presented at the American Heart Association International Stroke Conference.
Read More